NovaQuest Capital buys majority of Clinical Ink
NovaQuest Capital Management LLC has acquired a majority of Clinical Ink. Financial terms weren’t announced. RTI International co-invested with NovaQuest. Clinical Ink, of Winston-Salem, North Carolina, provides clinical research technology. Silicon Valley Bank also provided a flexible credit facility to Clinical Ink. Baird provided financial advice to Clinical Ink, while Hogan Lovells supplied legal advice. Wyrick Robbins provided legal advice to NovaQuest.
15 May 2018•4 mins read
